Rapid modernisation of diagnostic pathology in post-pandemic era
Proscia has introduced the next generation of its flagship Concentriq platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era.
The latest version delivers performance, functionality and design enhancements that drive meaningful quality and efficiency gains in routine pathology diagnosis for multi-site and remote operations.
Demand for digital pathology has surged as adapting to the pandemic and post-pandemic era has intensified systemic challenges long threatening the traditional laboratory model. The shift to remote work has disrupted the current standard of care centred around pathologists and microscopes in physical spaces, exacerbating mounting pressures created by a shrinking pathologist population, rising biopsy volume, and industry consolidation.
Laboratories are now rapidly seeking to modernise their pathology operations to further their commitment to excellent patient care; however, legacy software systems that do not scale across the enterprise or fit into the pathologist’s day-to-day workflow have prevented them from achieving this transformation.
Proscia’s Concentriq platform is used by top reference laboratories and health systems to shift the standard of care from microscope to image. The new release enables even the largest networked laboratories to rapidly adopt digital pathology by delivering the performance, security and connectivity needed to scale across distributed operations.
● Put the pathologist at the centre of a powerful new experience as intuitive as the microscope.
The latest version of Concentriq is designed to drive meaningful productivity and efficiency gains by delivering a natural, microscope-like viewing experience from within a robust digital pathology environment. Pathologists can now enhance their familiar workflow with streamlined sharing, improved access to expertise, and the ability to work remotely.
● Unify multi-site laboratory networks in a single, future-proof platform.
Geographically dispersed pathologists can carry out their day-to-day work from within a shared platform as if they were all practicing from one location. A single deployment of Concentriq now supports an unlimited number of sites and users, as well as multiple laboratory information systems (LIS) and scanner types, to meet their current and future needs.
● Accelerate case review and expand the breadth of diagnostic information with optional AI applications.
The next generation of Concentriq empowers laboratories to embrace pathology’s computational future with confidence. The platform’s open API enables users to seamlessly incorporate AI applications, including solutions developed by Proscia and other third parties, into routine operations and view results alongside all other pathology data.
“Digital and computational pathology is the only way we will continue to serve our patients in these unprecedented times, yet critical gaps in the underlying technology have prevented us from fully capitalising on our implementation,” said Dr Alexi Baidoshvili (pictured), Clinical Pathologist at LabPON, the first laboratory in the world to reach 100% digital pathology diagnosis. “Concentriq meets the needs both of our individual pathologists and large networked laboratory environment. With Concentriq, we can finally scale our adoption to drive quality and productivity gains while realising the promise of AI.”